Iron deficiency and malaria among children living on the coast of Kenya

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 439-447

  Nyakeriga, Alice M ^a,b,c,f   Troye Blomberg, Marita ^c   Dorfman, Jeffrey R ^a   Alexander, Neal D ^e   Bäck, Rune ^d   Kortok, Moses ^a   Chemtai, Alex K ^b   Marsh, Kevin ^a   Williams, Thomas N ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b MOI UNIVERSITY   (Kenya)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IMMUNOGLOBULIN; IRON;

ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HEALTH SURVEY; HUMAN; IMMUNE RESPONSE; INCIDENCE; IRON DEFICIENCY; KENYA; MAJOR CLINICAL STUDY; MALARIA; NUTRITIONAL STATUS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 3242812829     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422331     Document Type: Article

References (40)

1. Murray MJ, Murray NJ, Murray AB, Murray MB. Refeeding-malaria and hyperferraemia. Lancet 1975; 1:653-4.
2. Oppenheimer SJ, Gibson FD, Macfarlane SB, et al. Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. Trans R Soc Trop Med Hyg 1986; 80:603-12.
3. Smith AW, Hendrickse RG, Harrison C, Hayes RJ, Greenwood BM. The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. Ann Trop Paediatr 1989; 9:17-23.
4. Menendez C, Kahigwa E, Hirt R, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997; 350:844-50.
5. Verhoef H, West CE, Nzyuko SM, et al. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 2002; 360:908-14.
6. Berger J, Dyck JL, Galan P, et al. Effect of daily iron supplementation on iron status, cell-mediated immunity, and incidence of infections in 6-36 month old Togolese children. Eur J Clin Nutr 2000; 54:29-35.
7. Desai MR, Mei JV, Kariuki SK, et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis 2003; 187:658-66.
8. Shankar AH. Nutritional modulation of malaria morbidity and mortality. J Infect Dis 2000; 182(Suppl 1):S37-53.
9. Dhur A, Galan P, Hercberg S. Iron status, immune capacity and resistance to infections. Comp Biochem Physiol A 1989; 94:11-9.
10. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4.
11. Mbogo CN, Snow RW, Kabiru EW, et al. Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg 1993; 49:245-53.
12. Mwangi TW. Clinical epidemiology of malaria under differing levels of transmission [thesis]. Oxford: Open University, 2003.
13. Nicoll A, Ulijaszek S. Modifications of the AHRTAG child length measurer. Trop Doct 1987; 17:129-31.
14. Kasvosve I, Delanghe JR, Gomo ZA, et al. Transferrin polymorphism influences iron status in blacks. Clin Chem 2000; 46:1535-9.
15. Galan P, Thibault H, Preziosi P, Hercberg S. Interleukin 2 production in iron-deficient children. Biol Trace Elem Res 1992; 32:421-6.
16. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986; 58:305-23.
17. Perlmann H, Helmby H, Hagstedt M, et al. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol 1994; 97:284-92.
18. Troye-Blomberg M, Perlmann H, Patarroyo ME, Perlmann P. Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol 1983; 53:345-53.
19. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994; 13:2345-58.
20. Armitage P, Berry G, Matthews JNS. Using STATA's robust cluster command as appropriate. In: Armitage P, Berry G, Matthews JNS. Statistical methods in medical research. 4th ed. Oxford: Blackwell Scientific Publications, 2001:378-454.
21. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001; 131:616S-35S.
22. Harvey PW, Bell RG, Nesheim MC. Iron deficiency protects inbred mice against infection with Plasmodium chabaudi. Infect Immun 1985; 50:932-4.
23. Ances IG, Granados J, Baltazar M. Serum ferritin as an early determinant of decreased iron stores in pregnant women. South Med J 1979; 72:591-2, 604.
24. Jacob RA, Sandstead HH, Klevay LM, Johnson LK. Utility of serum ferritin as a measure of iron deficiency in normal males undergoing repetitive phlebotomy. Blood 1980; 56:786-91.
25. Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992; 60:1473-81.
26. Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E, Marsh K. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol 2002; 24:77-82.
27. Peto TE, Hershko C. Iron and infection. Baillieres Clin Haematol 1989; 2:435-58.
28. Bagchi K, Mohanram M, Reddy V. Humoral immune response in children with iron-deficiency anaemia. Br Med J 1980; 280:1249-51.
29. Krantman HJ, Young SR, Ank BJ, O'Donnell CM, Rachelefsky GS, Stiehm ER. Immune function in pure iron deficiency. Am J Dis Child 1982; 136:840-4.
30. Jarvis JH, Jacobs A. Morphological abnormalities in lymphocyte mitochondria associated with iron-deficiency anaemia. J Clin Pathol 1974; 27:973-9.
31. Raventos-Suarez C, Pollack S, Nagel RL. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg 1982; 31:919-22.
32. Fritsch G, Sawatzki G, Treumer J, Jung A, Spira DT. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin. Exp Parasitol 1987; 63:1-9.
33. Fritsch G, Treumer J, Spira DT, Jung A. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol 1985;60:171-4.
34. Adelekan DA, Thurnham DI. Plasma ferritin concentrations in anemic children: relative importance of malaria, riboflavin deficiency, and other infections. Am J Clin Nutr 1990; 51:453-6.
35. Yates SNR. Human genetic diversity and selection by malaria. Oxford: Institute of Molecular Medicine, 1995.
36. Rees DC, Williams TN, Maitland K, Clegg JB, Weatherall DJ. Alpha thalassaemia is associated with increased soluble transferrin receptor levels. Br J Haematol 1998; 103:365-9.
37. Gera T, Sachdev HP. Effect of iron supplementation on incidence of infectious illness in children: systematic review. BMJ 2002; 325:1142-52.
38. Pasvol G, Weatherall D, Wilson RJM. The increased susceptibility of young red cells to invasion by the malaria parasite Plasmodium falciparum. Br J Haematol 1980; 45:285-95.
39. Weiss G, Wachter H, Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today 1995; 16:495-500.
40. International Nutritional Anemia Consultative Group. Consensus statement: safety of iron supplementation programs in malaria-endemic regions. Washington, DC: International Life Sciences Institute's Human Nutrition Institute, 1998:1-6.